Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (DECREASE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04319783
Recruitment Status : Recruiting
First Posted : March 24, 2020
Last Update Posted : September 1, 2021
Sponsor:
Collaborators:
Bayer
Peter MacCallum Cancer Centre, Australia
Information provided by (Responsible Party):
Trans Tasman Radiation Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2026
Estimated Study Completion Date : June 2026